# Healthcare
Latest news and articles about Healthcare
Total: 13 articles found
Vice Premier Urges Stronger Primary Healthcare and Advances in Brain-Computer Interfaces
During a Tianjin inspection, Liu Guozhong called for expanding grassroots medical consortia while accelerating cutting-edge biomedical technology.
China Releases 15th Five-Year Plan for Universal Healthcare Security
The National Healthcare Security Administration sets targets for insurance coverage, direct maternity payouts, and long-term care expansion.
China Examines Rules and Efficiency for Medical Insurance Personal Accounts
State media coverage highlights ongoing policy efforts to mobilize dormant health insurance funds while enforcing regulatory boundaries.
China's Pharma Sector Sees Surge in Drug Approvals and Out-Licensing in H1
Domestic developers accounted for over 80% of new innovative drug approvals as overseas licensing deals hit $110 billion.
China Standardizes Medical Testing Fees Under National Pricing Framework
The National Healthcare Security Administration completes its 40-batch pricing overhaul, establishing unified rules for diagnostic lab tests.
E-Commerce Platforms Emerge as Primary Debut Channels for New Drugs in China
Leading platforms hosted debuts for the vast majority of innovative medicines in 2025, bypassing lengthy hospital procurement cycles.
China Directs Special Treasury Bond Funds to Public Healthcare and Housing Upgrades
A 200 billion yuan fund for equipment renewal now covers hospital machinery, residential elevators, and elderly care facilities.
China Standardizes 12th Bulk Drug Procurement Batch Covering 65 Categories
China's healthcare authority includes 65 drug varieties in its latest centralized procurement round, shifting toward longer contract terms and rational pricing.
Xi Jinping Outlines Healthcare Priorities for 15th Five-Year Plan
An upcoming Qiushi article highlights key reforms in public health, hospital governance, and digital health infrastructure.
China Issues Action Plan to Upgrade Grassroots TCM Services by 2030
A new national policy directive focuses on bolstering primary-level Traditional Chinese Medicine capabilities across local clinics and community health centers.
China Biopharma Advances Pipelines and Global Out-Licensing Transactions
National data and policy support highlight the sector's transition from follower-drug development to novel therapies, including ADCs.
Media Report Highlights Profit Surge at Joinn Laboratories
Mainland media coverage points to a reported net profit increase of over 1,300 percent for the preclinical research organization, focusing attention on biological asset valuations.